Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 20/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508251 | 1.00 | PTGER4 (0.79) | PTGER4 | |
| SCHEMBL5397220 | 0.93 | PTGER4 (0.72) | PTGER4 | |
| SCHEMBL5223597 | 0.89 | PTGER4 (1.00) | PTGER4 | |
| SCHEMBL2300769 | 0.85 | PTGER4 (1.00) | PTGER4 | |
| SCHEMBL5221211 | 0.84 | PTGER4 (0.87) | PTGER4 | |
| SCHEMBL1735898 | 0.81 | PTGER4 (0.85) | PTGER4 | |
| SCHEMBL3567548 | 0.81 | PTGER4 (0.94) | PTGER4 | |
| SCHEMBL3561049 | 0.81 | PTGER4 (0.94) | PTGER4 | |
| SCHEMBL3561068 | 0.80 | PTGER4 (0.90) | PTGER4 | |
| SCHEMBL3567596 | 0.80 | PTGER4 (0.90) | PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160030478-A1 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2016-02-04 | — | — | US | claimed |
| EP-2555774-B1 | Medicine combinations containing pde4 inhibitors and ep4 receptor antagonists | BOEHRINGER INGELHEIM INT (DE) | 2015-10-21 | — | — | EP | claimed |
| US-20140377214-A1 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2014-12-25 | — | — | US | claimed |
| US-8877758-B2 | Combinations of medicaments, containing PDE4-inhibitors and EP4-receptor-antagonists | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-11-04 | — | — | US | claimed |
| US-20140065706-A1 | MATERIALS AND METHODS FOR MOBILIZING CELLS INCLUDING CD34+, HEMATOPOIETIC COLONY FORMING, AND ENDOTHELIAL COLONY FORMING CELLS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) | 2014-03-06 | — | — | US | claimed |
| US-20140017339-A1 | MATERIALS AND METHODS FOR TREATING RADIATION POISONING | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) | 2014-01-16 | — | — | US | claimed |
| US-20130237527-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4-INHIBITORS AND EP4-RECEPTOR-ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-12 | — | — | US | claimed |
| US-20130225609-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4-INHIBITORS AND EP4-RECEPTOR-ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-08-29 | — | — | US | claimed |
| EP-2555773-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4 INHIBITORS AND EP4 RECEPTOR ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2013-02-13 | — | — | EP | claimed |
| EP-2555774-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4 INHIBITORS AND EP4 RECEPTOR ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2013-02-13 | — | — | EP | claimed |
| WO-2012061820-A2 | MATERIALS AND METHODS FOR TREATING RADIATION POISONING | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-05-10 | — | — | WO | claimed |
| WO-2012061822-A2 | MATERIALS AND METHODS FOR MOBILIZING CELLS INCLUDING CD34+, HEMATOPOIETIC COLONY FORMING, AND ENDOTHELIAL COLONY FORMING CELLS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-05-10 | — | — | WO | claimed |
| US-20120003189-A1 | Materials and Methods to Enhance Hematopoietic Stem Cells Engraftment Procedures | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2012-01-05 | — | — | US | claimed |
| WO-2011124524-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4 INHIBITORS AND EP4 RECEPTOR ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-10-13 | — | — | WO | claimed |
| WO-2011124525-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4 INHIBITORS AND EP4 RECEPTOR ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-10-13 | — | — | WO | claimed |
| EP-2362733-A1 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | Indiana University Research Technology Corporation (US) | 2011-09-07 | — | — | EP | claimed |
| WO-2010054271-A1 | MATERIALS AND METHDS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-05-14 | — | — | WO | claimed |
| US-20040087624-A1 | Benzo (f) insoindol derivatives and their use as ep4 receptor ligands | GLAXO GROUP LIMITED (GB) | 2004-05-06 | — | — | US | claimed |
| EP-3824884-A1 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | Indiana University Research and Technology Corporation (US) | 2021-05-26 | — | — | EP | disclosed |
| US-20040087624-A1 | Benzo (f) insoindol derivatives and their use as ep4 receptor ligands | GLAXO GROUP LIMITED (GB) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225609-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4-INHIBITORS AND EP4-RECEPTOR-ANTAGONISTS | PTGER4, PTGER1, PDE4A | PTGER4 1/4885 |
| US-20040087624-A1 | Benzo (f) insoindol derivatives and their use as ep4 receptor ligands | PTGER4, PTGER1, OPRL1 | PTGER4 1/4885 |
| US-20130237527-A1 | COMBINATIONS OF MEDICAMENTS, CONTAINING PDE4-INHIBITORS AND EP4-RECEPTOR-ANTAGONISTS | PTGER4, PTGER1, PTGER3 | PTGER4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.